Markus Reindl

28.4k total citations · 4 hit papers
251 papers, 13.2k citations indexed

About

Markus Reindl is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Markus Reindl has authored 251 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pathology and Forensic Medicine, 137 papers in Neurology and 57 papers in Rheumatology. Recurrent topics in Markus Reindl's work include Multiple Sclerosis Research Studies (153 papers), Peripheral Neuropathies and Disorders (108 papers) and Systemic Lupus Erythematosus Research (49 papers). Markus Reindl is often cited by papers focused on Multiple Sclerosis Research Studies (153 papers), Peripheral Neuropathies and Disorders (108 papers) and Systemic Lupus Erythematosus Research (49 papers). Markus Reindl collaborates with scholars based in Austria, Germany and United States. Markus Reindl's co-authors include Thomas Berger, Florian Deisenhammer, Werner Poewe, Kathrin Schanda, Patrick Waters, Nadia Stefanova, Gregor K. Wenning, Kevin Rostásy, Franziska Di Pauli and Stefan Kiechl and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Markus Reindl

245 papers receiving 12.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toll-like Receptor 4 Polymorphisms and Atherogenesis

2002 820 citations Stefan Kiechl, Markus Reindl et al. profile →
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

2012 553 citations Kathrin Schanda, Markus Reindl et al. profile →
Myelin oligodendrocyte glycoprotein antibodies in neurological disease

2018 393 citations Markus Reindl, Patrick Waters profile →
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

2015 271 citations Patrick Waters, Mark Woodhall et al. profile →

Peers

Countries citing papers authored by Markus Reindl

Since Specialization

Citations

This map shows the geographic impact of Markus Reindl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Reindl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Reindl more than expected).

Fields of papers citing papers by Markus Reindl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Reindl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Reindl. The network helps show where Markus Reindl may publish in the future.

Co-authorship network of co-authors of Markus Reindl

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Reindl. A scholar is included among the top collaborators of Markus Reindl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Reindl. Markus Reindl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD 2025 ·Therapeutic Advances in Neurological Disorders ·Patrick Schindler, Ulrike Grittner, Rebekka Rust, Susanna Asseyer, Judith Bellmann–Strobl, Tanja Schmitz‐Hübsch, Michael Scheel, Sven Jarius, Brigitte Wildemann, Markus Reindl, Pascal Benkert, Jens Kühle, Friedemann Paul, Klemens Ruprecht, Claudia Chien	0
2	Inflammatory transcriptomic signatures in a human cellular NMOSD model reveal upregulation of NF-κB and IL6 pathways 2025 ·Scientific Reports ·(unknown), (unknown), Judith Hagenbuchner, Verena Endmayr, Romana Höftberger, Monika Bradl, Markus Reindl	0
3	Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders 2024 ·European Journal of Paediatric Neurology ·(unknown), Christian Lechner, Markus Breu, (unknown), Mareike Schimmel, Astrid Eisenkölbl, (unknown), Eva‐Maria Wendel, Markus Reindl, Kevin Rostásy, Matthias Baumann	2
4	Children with MOG-IgG positive bilateral optic neuritis misdiagnosed as fulminant idiopathic intracranial hypertension 2024 ·Multiple Sclerosis and Related Disorders ·Eva‐Maria Wendel, Daniel Tibussek, Nina Barišić, (unknown), (unknown), (unknown), Tobias Geis, Ellen Knierim, (unknown), Margherita Nosadini, Stefano Sartori, (unknown), (unknown), Markus Reindl, Thivya Pakeerathan, Ilya Ayzenberg, Kevin Rostásy	1
5	High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis 2023 ·European Journal of Neurology ·Arabella Buchmann, Lukas Pirpamer, Daniela Pinter, Margarete M. Voortman, (unknown), Alexander Pichler, Aleksandra Maleska Maceski, Pascal Benkert, Gerhard Bachmaier, Stefan Ropele, Markus Reindl, David Leppert, Jens Kühle, Christian Enzinger, Michael Khalil	8
6	Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5 2023 ·Microbiology Spectrum ·Gabriel Diem, Michael Jäger, Stefanie Dichtl, (unknown), Cornelia Lass‐Flörl, Markus Reindl, Doris Wilflingseder, Wilfried Posch	1
7	Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models 2023 ·International Journal of Molecular Sciences ·(unknown), Markus Reindl	40
8	Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen 2022 ·The Journal of Infectious Diseases ·Michael Jäger, Stefanie Dichtl, Rosa Bellmann‐Weiler, Markus Reindl, Cornelia Lass‐Flörl, Doris Wilflingseder, Wilfried Posch	7
9	Complement Activation Is a Prominent Feature of MOGAD 2021 ·Annals of Neurology ·Christian W. Keller, Joseph A. Lopez, Eva‐Maria Wendel, Sudarshini Ramanathan, Catharina C. Groß, Luisa Klotz, Markus Reindl, Russell C. Dale, Heinz Wiendl, Kevin Rostásy, Fabienne Brilot, Jan D. Lünemann	35
10	NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 2021 ·Multiple Sclerosis and Related Disorders ·Sara Mariotto, Matteo Gastaldi, Luisa Grazian, Chiara Mancinelli, Ruggero Capra, Romain Marignier, Daniela Alberti, Serena Zanzoni, Kathrin Schanda, Diego Franciotta, (unknown), Salvatore Monaco, Markus Reindl, Sérgio Ferrari, Alberto Gajofatto	20
11	German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis 2021 ·BMC Neurology ·(unknown), Roger Mills, Markus Reindl, Laura Zamarian, (unknown), Christian Brenneis, Rainer Ehling, Florian Deisenhammer	3
12	High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy 2020 ·Journal of Neuroinflammation ·Antonio Heras‐Garvin, (unknown), Markus Reindl, Gregor K. Wenning, Nadia Stefanova	14
13	Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study 2019 ·Journal of Neuroinflammation ·Frederike Cosima Oertel, Olivier Outteryck, Benjamin Knier, Hanna Zimmermann, Nadja Borisow, Judith Bellmann–Strobl, Astrid Blaschek, Sven Jarius, Markus Reindl, Klemens Ruprecht, Edgar Meinl, Reinhard Hohlfeld, Friedemann Paul, Alexander U. Brandt, Tania Kümpfel, Joachim Havla	44
14	German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol 2019 ·BMJ Open ·(unknown), Roger Mills, Markus Reindl, Laura Zamarian, Raija Kuisma, (unknown), Christian Brenneis, Rainer Ehling, Florian Deisenhammer	4
15	Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial 2015 ·Journal of Neuroimmunology ·Rainer Ehling, Franziska Di Pauli, Peter Lackner, Carolyn Rainer, (unknown), Harald Hegen, Andreas Lutterotti, Bettina Kuenz, Tobias De Zordo, Michael Schocke, (unknown), Wolfgang N. Löscher, Florian Deisenhammer, Markus Reindl, Thomas Berger	10
16	Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells 2014 ·Multiple Sclerosis Journal ·Patrick Peschl, Markus Reindl, Kathrin Schanda, Mireia Sospedra, Roland Martinꝉ, Andreas Lutterotti	9
17	Antibodies to Myelin Oligodendrocyte Glycoprotein (MOG) in Children and Adults with Demyelinating Disorders (NMO) 2013 ·Annals of Neurology ·Patrick Waters, Mark Woodhall, Yael Hacohen, Kevin C. O’Connor, Michael Absoud, Jackie Palace, Markus Reindl, Ming Lim, Maria Isabel Leite, Angela Vincent	3
18	Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay 2009 ·International Journal of Epidemiology ·Silvia Ehrlenbach, Peter Willeit, Stefan Kiechl, Johann Willeit, Markus Reindl, Kathrin Schanda, Florian Kronenberg, Anita Kloss‐Brandstätter	152
19	Epitope Specificity of Neutralizing Antibodies Against IFN-β 2004 ·Journal of Interferon & Cytokine Research ·Claudia Gneiss, Markus Reindl, Thomas Berger, Andreas Lutterotti, Rainer Ehling, R. Egg, Florian Deisenhammer	22
20	Immunoglobulin Subclasses in Patients with Neutralizing and Nonneutralizing Antibodies Against IFN-β1b 2001 ·Journal of Interferon & Cytokine Research ·Florian Deisenhammer, Markus Reindl, Thomas Berger	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact